IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1151-1175 out of 1247.

<< < 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 > >>

Public Release: 7-May-2014
IMPAKT 2014 Breast Cancer Conference
International molecular screening program for metastatic breast cancer AURORA at IMPAKT
AURORA is the first international research program of its kind aiming to improve the lives of patients with metastatic breast cancer. Recently launched by the Breast International Group, it will be presented by Martine Piccart-Gebhart at the IMPAKT Breast Cancer Conference on Saturday, May 10, during a session devoted to new drugs and trials.

Contact: Cecilia Waldvogel
Breast International Group (BIG)-aisbl

Public Release: 7-May-2014
2014 ARRS Annual Meeting
CT-guided irreversible electroporation safe in unresectable pancreatic carcinoma
A small group of patients with locally advanced unresectable pancreatic carcinoma suffered no major ill effects -- pancreatitis or fistula formation -- after undergoing percutaneous CT-guided irreversible electroporation.

Contact: Lissa D. Hurwitz
American Roentgen Ray Society

Public Release: 7-May-2014
Journal of the Americal Chemical Society
Researchers use DNA to build tool that may literally shine light on cancer
Bioengineers at the University of Rome Tor Vergata and the University of Montreal have used DNA to develop a tool that detects and reacts to chemical changes caused by cancer cells and that may one day be used to deliver drugs to tumor cells.

Contact: William Raillant-Clark
University of Montreal

Public Release: 7-May-2014
2014 SID Annual Meeting
Regular doctor visits may greatly diminish skin cancer deaths
The risk of dying from the most dangerous type of skin cancer is significantly reduced with regular doctor visits, according to a Henry Ford Hospital study. This is believed to be the first study of its kind to link melanoma mortality with routine health care use.
Henry Ford Hospital, Henry Ford Medical Group and Dermatology Foundation

Contact: David Olejarz
Henry Ford Health System

Public Release: 7-May-2014
2014 ARRS Annual Meeting
Breast tomosynthesis after screening mammography reduces need for ultrasound, biopsies
Breast tomosynthesis in the diagnostic workup for one- or two-view focal asymmetry detected at screening mammography resulted in less use of ultrasound, fewer biopsies, and higher positive predictive value for cancer than when diagnostic exams involved only 2-D mammography.

Contact: Lissa D. Hurwitz
American Roentgen Ray Society

Public Release: 7-May-2014
Nature Cell Biology
Vascular simulation research reveals new mechanism that switches in disease
New clues to endothelial cell behavior are emerging from vascular simulation research. Recent papers from the Center for Vascular Biology Research at Beth Israel Deaconess Medical Center focus on this interdisciplinary field.

Contact: Bonnie Prescott
Beth Israel Deaconess Medical Center

Public Release: 6-May-2014
ACS Nano
Two-lock box delivers cancer therapy
Rice University scientists have designed a tunable virus that works like a safe deposit box. It takes two keys to open it and release its therapy for cancer and other diseases.

Contact: David Ruth
Rice University

Public Release: 6-May-2014
Preventive Medicine
College kids need to change unhealthy ways
A new study from Northwestern Medicine and Northeastern Illinois University found that the majority of college students are engaging in unhealthy behaviors that could increase their risk of cancer later on.
NIH/National Cancer Institute

Contact: Erin White
Northwestern University

Public Release: 6-May-2014
Stem Cell Reports
Ability to isolate and grow breast tissue stem cells could speed cancer research
By carefully controlling the levels of two proteins, researchers at the Salk Institute have discovered how to keep mammary stem cells -- those that can form breast tissue -- alive and functioning in the lab. The new ability to propagate mammary stem cells is allowing them to study both breast development and the formation of breast cancers.

Contact: Chris Emery
Salk Institute

Public Release: 5-May-2014
BJU International
Low testosterone levels may indicate worsening of disease for men with prostate cancer
For men with low-risk prostate cancer, low levels of testosterone may indicate a worsening of their disease.

Contact: Evelyn Martinez

Public Release: 5-May-2014
Molecular Systems Biology
Glutamine ratio is key ovarian cancer indicator
A Rice University-led analysis of the metabolic profiles of hundreds of ovarian tumors has revealed a new method for tailoring treatments for ovarian cancer and for assessing whether ovarian cancer cells have the potential to metastasize.
Rice's Ken Kennedy Institute, MD Anderson's Odyssey Fellows Program, National Institutes of Health, Cancer Prevention Research Institute of Texas, Gilder Foundation

Contact: Jade Boyd
Rice University

Public Release: 5-May-2014
Digestive Disease Week
Researchers present findings on promising biomarker for esophageal cancer
A new biomarker for esophageal cancer shows promise in improving screening for this deadly disease and its precursor, Barrett's esophagus. Amitabh Chak, M.D., of University Hospitals Case Medical Center's Seidman Cancer Center and Case Western Reserve University School of Medicine, presented findings today at Digestive Disease Week in Chicago in a research forum titled 'Aberrant Vimentin Methylation in Esophageal Brushings: A Biomarker for Detecting Barrett's Esophagus and Esophageal Adenocarcinoma.'
NIH/National Cancer Institute

Contact: Alicia Reale
University Hospitals Case Medical Center

Public Release: 5-May-2014
Having eczema may reduce your risk of skin cancer
Eczema caused by defects in the skin could reduce the risk of developing skin cancer, according to new research by King's College London. The immune response triggered by eczema could help prevent tumor formation by shedding potentially cancerous cells from the skin.
Medical Research Council, Wellcome Trust, Cancer Research UK

Contact: Jack Stonebridge
King's College London

Public Release: 5-May-2014
Digestive Disease Week
Dual method to remove precancerous colon polyps may substantially reduce health-care costs
A surgical method combining two techniques for removing precancerous polyps during colonoscopies can substantially reduce the recovery time and the length of hospital stays, potentially saving the health-care system millions of dollars, according to research presented today at Digestive Disease Week.

Contact: Aimee Frank
Digestive Disease Week

Public Release: 5-May-2014
JAMA Internal Medicine
Choosing a screening method for cervical cancer: Pap alone or with HPV test
Karen Smith-McCune, M.D., Ph.D., of the University of California, San Francisco, writes: 'The updated guidelines leave physicians and other clinicians with a question: is cotesting with Pap-plus-HPV testing truly preferred over Pap testing alone (the American Cancer Society/the American Society of Colposcopy and Cervical Pathology/the American Society of Clinical Pathology recommendation), or are the options equivalent (the US Preventive Services Task Force recommendation)?'

Contact: Elizabeth Fernandez
The JAMA Network Journals

Public Release: 5-May-2014
Molecular Cancer Therapeutics
Bioinformatics approach helps researchers find new uses for old drug
Developing and testing a new anti-cancer drug can cost billions of dollars and take many years of research. Now using a bioinformatics approach, a team from Beth Israel Deaconess Medical Center has identified an approved antimicrobial drug that may help patients with advanced kidney cancer.
National Institutes of Health, CAPES International Fellowship

Contact: Bonnie Prescott
Beth Israel Deaconess Medical Center

Public Release: 5-May-2014
Journal of National Cancer Institute
Focused ultrasound reduces cancer pain
Non-invasive focused ultrasound thermal therapy reduces pain from bone metastases.

Contact: Edyta Zielinska
Thomas Jefferson University

Public Release: 5-May-2014
Canadian Journal of Cardiology
Hypertension related to new cancer therapies -- a new syndrome emerges
New cancer therapies, particularly agents that block vascular endothelial growth factor (VEGF) signaling, have improved the outlook for patients with some cancers and are now used as a first line therapy for some tumors. However, almost 100 percent of patients who take VEGF inhibitors (VEGFIs) develop high blood pressure, and a subset develops severe hypertension. The mechanisms underlying VEGF inhibitor-induced hypertension need to be better understood and there is a need for clear guidelines and improved management, say investigators.

Contact: Eileen Leahy
Elsevier Health Sciences

Public Release: 5-May-2014
Annals of Internal Medicine
WHI reports $37.1 billion economic return on combined hormone therapy clinical trial
The overall economic return from the Women's Health Initiative E+P trial indicates that changes in practice stemming from the trial provided a net economic return of $37.1 billion over the 10-year period since the main findings were published.

Contact: Michael Nank
Fred Hutchinson Cancer Research Center

Public Release: 5-May-2014
American Journal of Geriatric Psychiatry
Dementia diagnosis twice as likely if older adult has schizophrenia; cancer less likely
Regenstrief Institute and Indiana University researchers who followed over 30,000 older adults for a decade have found the rate of dementia diagnosis for patients with schizophrenia to be twice as high as for patients without this chronic, severe and disabling brain disorder. Cancer, however, was less likely.
NIH/National Institute of Mental Health, NIH/National Institute on Aging

Contact: Cindy Fox Aisen
Indiana University

Public Release: 5-May-2014
Proceedings of the National Academy of Sciences
Where DNA's copy machine pauses, cancer could be next
A comprehensive mapping of the 'fragile sites' where chromosomes are more likely to experience breakage shows the damage appears in specific areas of the genome where the DNA copying machinery is slowed or stalled during replication, either by certain sequences of DNA or by structural elements. The May 5 PNAS study could give insight into the origins of many of the genetic abnormalities seen in solid tumors.
National Institutes of Health

Contact: Karl Bates
Duke University

Public Release: 5-May-2014
PLOS Medicine
Liver cancer screening highly beneficial for people with cirrhosis
Liver cancer survival rates could be improved if more people with cirrhosis are screened for tumors using inexpensive ultrasound scans and blood tests, according to a review by doctors at UT Southwestern Medical Center.

Contact: Patrick McGee
UT Southwestern Medical Center

Public Release: 5-May-2014
The Oncologist
Molecular tumor board helps in advanced cancer cases
With accelerating development of personalized cancer treatments matched to a patient's DNA sequencing, proponents say front-line physicians increasingly need help to maneuver through the complex genomic landscape to find the most effective, individualized therapy.
MyAnswerToCancer, Joan and Irwin Jacobs Fund

Contact: Scott LaFee
University of California - San Diego

Public Release: 2-May-2014
Stem Cell Reports
A transcription factor called SLUG helps determines type of breast cancer
A study in Stem Cell Reports determines that the transcription factor SLUG plays a role in regulating stem cell function. In mice without SLUG, basal cells are reprogrammed into a luminal-cell fate, luminal cells hyper-proliferate, and stem-cell function necessary for tissue regeneration and tumor initiation is inhibited.
Breast Cancer Foundation, NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH/National Cancer Institute, NIH/National Center for Research Resources, NIH/National Center for Advancing Translational Sciences

Contact: Siobhan Gallagher
Tufts University, Health Sciences Campus

Public Release: 2-May-2014
Better sleep predicts longer survival time for women with advanced breast cancer
A new study reports that sleep efficiency, a ratio of time asleep to time spent in bed, is predictive of survival time for women with advanced breast cancer.
National Institutes of Health

Contact: Lynn Celmer
American Academy of Sleep Medicine

Showing releases 1151-1175 out of 1247.

<< < 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 > >>

  Search News Releases